Regulatory Updates
🇪🇺 EMA Page 12EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 133–144 of 171 articles
The Future of European Medicine: The Role of Clinical Research
Europe's Drug Innovation Edge at Risk: Insights from Dutch Industry Group
Breast Cancer Insights: Key Abstracts for ESMO 2026
NICE Approves Imfinzi for Stomach Cancer: Regulatory Update
Q1 2026 Life Sciences Law Update: Clinical Trials Insights
EMA's Political Agreement on Critical Medicines Act: Market Implications
Regulatory Round-Up: Key Updates from 11 May 2026
NICE Endorses Imfinzi for Stomach Cancer: Regulatory Insights
Europe's Biotech Dilemma: Balancing Discovery and Scaling
Roche's Elevidys Study Launch: Navigating EU Rejection
Latest New Meds Recommended for Approval by EMA’s CHMP
Countries Compete to Reform Trials to Attract Global Sponsors